Related references
Note: Only part of the references are listed.Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods
Zihuai Wang et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2021)
Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer
Cagatay Tezel et al.
THORACIC AND CARDIOVASCULAR SURGEON (2020)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study
Bing Chen et al.
THORACIC CANCER (2019)
The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications
Wanyin Lim et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2018)
Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer
Yong-Kui Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Nodal Stage of Surgically Resected Non-Small Cell Lung Cancer and Its Effect on Recurrence Patterns and Overall Survival
John M. Varlotto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Predictive Factors of Lymph Node Status in Small Peripheral Non-small Cell Lung Cancers: Tumor Histology is More Reliable
Yang Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Treatment of Stage I and II Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John A. Howington et al.
CHEST (2013)
Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status
Akiko Miyagi Maeshima et al.
CANCER (2012)
The Number of Lymph Node Metastases as a Prognostic Factor in Patients With N1 Non-small Cell Lung Cancer
Sirisha Jonnalagadda et al.
CHEST (2011)
Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non-Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
Charles A. Butts et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis
Kei Miyoshi et al.
SURGERY TODAY (2010)
The IASLC Lung Cancer Staging Project A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer
Valerie W. Rusch et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
